Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Urologia Internationalis
|
December 11, 1999
A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer
A M Senderowicz, R Reid, D Headlee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells
R W Robey, W Y Medina-Pérez, K Nishiyama, et al.
The Journal of Clinical Investigation
|
November 5, 1998
Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis
V Patel, A M Senderowicz, D Pinto, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton
A M Senderowicz, G Kaur, E Sainz, et al.
The Journal of Biological Chemistry
|
December 5, 1998
UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase
L Yu, L Orlandi, P Wang, et al.
Blood
|
January 15, 1998
Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol
B W Parker, G Kaur, W Nieves-Neira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm
W H Wilson, L Sorbara, W D Figg, et al.
Cancer Chemotherapy and Pharmacology
|
September 28, 1998
Clinical pharmacology of UCN-01: initial observations and comparison to preclinical models
E A Sausville, R D Lush, D Headlee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
A M Senderowicz, D Headlee, S F Stinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer
N A Dawson, W D Figg, M R Cooper, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Urologia Internationalis
|
December 11, 1999
A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer
A M Senderowicz, R Reid, D Headlee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2001
Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells
R W Robey, W Y Medina-Pérez, K Nishiyama, et al.
The Journal of Clinical Investigation
|
November 5, 1998
Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis
V Patel, A M Senderowicz, D Pinto, et al.
Journal of the National Cancer Institute
|
January 4, 1995
Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton
A M Senderowicz, G Kaur, E Sainz, et al.
The Journal of Biological Chemistry
|
December 5, 1998
UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase
L Yu, L Orlandi, P Wang, et al.
Blood
|
January 15, 1998
Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol
B W Parker, G Kaur, W Nieves-Neira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm
W H Wilson, L Sorbara, W D Figg, et al.
Cancer Chemotherapy and Pharmacology
|
September 28, 1998
Clinical pharmacology of UCN-01: initial observations and comparison to preclinical models
E A Sausville, R D Lush, D Headlee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
A M Senderowicz, D Headlee, S F Stinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer
N A Dawson, W D Figg, M R Cooper, et al.
Page
of 4